does it cover?

Does Medicare cover Zepbound?

DOESITCOVER.COM · GENERAL VERDICT · DOESITCOVER.COM · GENERAL VERDICT ·ITDEPENDS

It depends

Whether Medicare covers Zepbound depends on why and how: a temporary Medicare GLP-1 Bridge program (starting July 1, 2026) covers the Zepbound KwikPen for weight loss at a $50 monthly copay if you qualify, and a Part D plan can separately cover Zepbound for an approved medical indication like obstructive sleep apnea.

  • Covered when You qualify for the temporary Medicare GLP-1 Bridge program (Part D enrollee, 18+, meets the BMI/condition rules) — the Zepbound KwikPen is covered for weight loss at a $50 monthly copay with prior authorization.
  • Covered when It's prescribed for a covered medical indication (e.g., obstructive sleep apnea) and is on your Part D plan's formulary, usually with prior authorization.
  • Not when You don't meet the Bridge program's eligibility, it's for weight loss alone, and your Part D plan doesn't otherwise list Zepbound — you'd pay cash or request an exception.

What flips the answer

  • Covered when

    You qualify for the temporary Medicare GLP-1 Bridge program (Part D enrollee, 18+, meets the BMI/condition rules) — the Zepbound KwikPen is covered for weight loss at a $50 monthly copay with prior authorization.

  • Covered when

    It's prescribed for a covered medical indication (e.g., obstructive sleep apnea) and is on your Part D plan's formulary, usually with prior authorization.

  • Not covered when

    You don't meet the Bridge program's eligibility, it's for weight loss alone, and your Part D plan doesn't otherwise list Zepbound — you'd pay cash or request an exception.

Key facts

Verdict
It depends
Applies to
Zepbound · Medicare
Covered when
You qualify for the temporary Medicare GLP-1 Bridge program (Part D enrollee, 18+, meets the BMI/condition rules) — the Zepbound KwikPen is covered for weight loss at a $50 monthly copay with prior authorization.
Not covered when
You don't meet the Bridge program's eligibility, it's for weight loss alone, and your Part D plan doesn't otherwise list Zepbound — you'd pay cash or request an exception.
Verified
2026-07-03 · 2 primary sources

Zepbound (tirzepatide) is a GLP-1/GIP medication. Standard Medicare Part D drug plans have generally excluded drugs used for weight loss, so a prescription written purely for obesity historically wasn't a covered Part D benefit.

That changed for eligible people on July 1, 2026. Under the temporary, nationwide Medicare GLP-1 Bridge program, Medicare covers certain GLP-1 drugs for weight loss at a $50 monthly copay — and the covered list includes the Zepbound KwikPen (single-dose Zepbound vials and pens aren't covered). You must have Part D, be 18 or older, and meet BMI-based eligibility (BMI of 35+, or 30–34.99 or 27–29.99 with a qualifying condition), with prior authorization and a diet-and-exercise program.

There's also a separate medical path. Zepbound is FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity. If you have OSA (or type 2 diabetes), you generally aren't in the Bridge program — instead your own Part D plan may cover Zepbound for that indication, subject to its formulary, prior authorization, and tier.

Original Medicare (Parts A and B) doesn't cover self-administered drugs like this, so any coverage runs through a Part D plan or the Bridge program. Whether your plan lists Zepbound, and at what cost, varies plan to plan.

What people typically pay

With coverage

Through the GLP-1 Bridge program (starting July 1, 2026), the Zepbound KwikPen for weight loss is a flat $50 copayment for a one-month supply for those who qualify. That $50 doesn't count toward your Part D deductible or out-of-pocket limit. If a Part D plan covers Zepbound for a medical indication instead, you'll pay that plan's tier cost sharing, which varies widely by plan.

Without coverage

Without any coverage applying, you'd pay the full cash price for Zepbound, which can be substantial for a month's supply; a manufacturer savings program or drug discount sites may lower what you pay depending on eligibility.

Costs vary by plan, the specific indication, and whether you use a manufacturer savings offer or discount card, so treat any dollar figure as an approximation.

How to actually get it covered

  1. Confirm you're enrolled in a Medicare Part D drug plan — Original Medicare (Parts A and B) alone won't cover a self-administered drug like Zepbound.

  2. Decide which path fits: the weight-loss Bridge program (if you're 18+ and meet the BMI/condition rules) or Part D coverage for a medical indication such as obstructive sleep apnea or type 2 diabetes.

  3. Ask your prescriber to document your BMI, any qualifying condition, and your diet-and-exercise lifestyle program, and to prescribe the covered Zepbound KwikPen (not vials or single-dose pens) for the Bridge program.

  4. Have your prescriber send the prescription and, when requested, complete the prior authorization before filling — coverage for either path generally requires it.

  5. Check your plan's formulary and tier (or the Bridge program's $50 copay) so you know what you'll owe at the pharmacy.

  6. If you're denied, request a coverage determination and, if needed, a formulary exception or appeal, with your prescriber providing supporting medical records.

Common questions

How is the $50 Bridge program copay different from what my Part D plan would charge?

The GLP-1 Bridge program sets a flat $50 monthly copay for the covered Zepbound KwikPen when you qualify for weight-loss coverage, regardless of your plan's normal tiers. Because a separate Medicare program covers it, that $50 doesn't count toward your Part D deductible or out-of-pocket limit and can't be lowered by Extra Help. If instead your Part D plan covers Zepbound for a medical indication like sleep apnea, you pay that plan's cost sharing for its formulary tier, which can be higher or lower than $50 and varies by plan.

I have type 2 diabetes — does that change how Medicare treats my Zepbound prescription?

Yes. People with type 2 diabetes (or moderate-to-severe sleep apnea, or fatty liver disease) aren't eligible for the weight-loss Bridge program; instead your own Part D plan may cover a GLP-1 for that condition. Whether it's approved depends on the plan's formulary, prior authorization rules, and tier, so check your plan's drug list.

Why won't Medicare cover my Zepbound vials or single-dose pens?

The Bridge program's covered list is specifically the Zepbound KwikPen — single-dose Zepbound vials and pens aren't included. If you're prescribed a form that isn't covered, you'd either switch to the KwikPen with your prescriber, pursue coverage under your Part D plan for a medical indication, or pay cash.

What happens if my prior authorization for Zepbound is denied?

If a Part D plan denies coverage, you can request a coverage determination and, if needed, a redetermination (appeal), and your prescriber can submit supporting documentation. You can also ask your plan for a formulary exception if the drug isn't listed. While you wait, you'd generally pay out of pocket or look at other savings options like a manufacturer program or drug discount sites.

Do the BMI rules require me to have a second health condition?

Not always. A BMI of 35 or higher qualifies on its own. A BMI of 30 or higher qualifies if you also have a condition like diastolic heart failure, uncontrolled high blood pressure, or stage 3a+ chronic kidney disease; a BMI of 27 or higher qualifies with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. All applicants must have Part D, be 18 or older, and use the drug as part of a diet-and-exercise lifestyle program, with prior authorization when requested.

That's the general answer. Yours is written in your actual policy.

Drop in your policy or benefits document and get the answer for your exact coverage — with the clause it comes from. Nothing is stored.

Check my policy →

Sources

  1. [01]Medicare.gov — Weight loss drugs (GLP-1 Bridge program)
  2. [02]Medicare.gov — Prescription drugs (outpatient / Part D)

People also ask